We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

November 3, 2018

The Pulse of Digital Health in India

Events
Chandana Fitzgerald
&
32 degree centigrade, the sun bright in your face in the Northern Hemisphere in November. That's the Mumbai we came to for HealthXLs Global Gathering with Abbott. Bang in the middle of Embarcaderoseque Bandra-Kurla Complex, Trident BKC is where healthcare leaders from India and abroad came together to discuss healthcare in India in its digital era. The healthcare infrastructure in India is mixed- some state of the art, planned centers and some understaffed and unequipped centers, lack of clear regulatory guidelines, varying demographics and affordability among its people, a booming economy with a burgeoning population. A mammoth challenge at hand indeed. HXLGG participants were more than ready to embrace it.  

Patient Centricity: India Has Made the Patient its Most Important Consumer

We decided to focus on topical issues and solutions to the Indian society. One thing India has done extremely well is catering to patients as consumers. The benefit of a tech-empowered population is that patients are very ready to partake in their health via e-means. Mail order pharmacy, e-prescription, e-diagnostics, e-health education are all things India has championed and mastered. When you have a large population, guess what you learn to do well - supply chain management, scalability and affordability. All our speakers and panelists on the patient-centricity session echoed these ideas.

Opening the day was Gaurav Agarwal, CTO of 1mg, India's largest platform for healthcare e-commerce. 1mg allows end-to-end management of a patient's wellness/ sickness journey - from e-consults, to e-prescription, home delivery of meds, and e-diagnostics.

Naiyya Saggi, CEO of Baby Chakra, the bundle of energy that she is wowed the audience with how her online platform for mums to be and infants has truly impacted increased antenatal awareness and care, and made the journey through pregnancy less stressful for the mother and ensured better breastfeeding, weaning and nutrition practices for the baby.

Dr Ram Narain, Executive Director of one of the top tertiary centers in Mumbai, Kokilaben Hospital, highlighted the gaps that exist in the way providers are currently delivering healthcare in India (comparing the hospital industry with the aviation industry, he drew how hospital committed errors have led to more deaths than aviation accidents). Technology could bridge those gaps - India has good technology and great people (providers). The focus needs to shift to educating patients on their wellness and sickness in the times between visits to decrease the dependency on the 'hospital' or the 'doctor'.

What ensued was a gripping panel discussion where the above folks were joined by Sachin Malhotra, CEO of TC4A and Raghu Gullapalli, Exec Director of Emerging Technologies at LVPEI. The panelists were all in agreement about what constitutes a 'patient-centric' solution in the context of India - that affordability and scalability are key. While Sachin emphasized on how many of the frugal innovations from India can be exported to similar settings and this is a shining example for the world, Raghu spoke of how they're taking tertiary care to the hinterland.

Not for one moment should we doubt the quality of offerings in India - the panelists hammered home that evidence of efficacy and validation of various technologies is a must and that this cannot take a backseat in the name of making a solution more economical. Through their offerings, some of them have mapped out patient journeys so they are able to personalise the offerings to each patient because in India, no two regions are the same in cultural practices/ beliefs, language, etc, and a one-size fits all approach is simply not going to work on a billion people. It is pretty clear to us that in India, patient centricity is not merely 'nice to have'.



The Growing Burden of Non-Communicable Disease

Gerald Jaideep, CEO of Medvarsity, an online education platform for HCPs in India, opened the session on NCDs (non-communicable disease, a.k.a, chronic disease, cancer, mental health conditions etc). Education is what helped Indians become more aware about polio immunization that ultimately led to its eradication in 2014, and it was education delivered via print and AV media several years ago that encouraged people to observe family planning that limited family sizes to two children per couple. What China accomplished with policy, India did with education.

Dr Prof Srinath Reddy, President of the Public Health Foundation of India who also wears many other hats as a researcher, teacher, policy enabler, advocate and activist cast a spell on the audience while he spoke of how health policy in India is changing with the changing healthcare ecosystem. He outlined the Ayushman Bharat program, India’s own Obamacare, just way bigger, and the implications it may have for comprehensive primary healthcare, in expanding service delivery package and promoting wellness, and providing universal health coverage, something India has struggled with over the last many decades due to sheer scale.

Dr YK Gupta, former Dean of AIIMS Pharmacology and the President of the Dept of Biotechnology for India waved the flag for AI (artificial intelligence) and outlined how patient safety while managing their NCDs, better therapeutics for NCDs can be created by channeling data we have on drug history and interactions, nutrition history, and other such person-specific information.

Three strong entrepreneurs, Manjiri Bakre of Oncostem Diagnostics, Abhishek Shah of Wellthy Therapeutics and Ramakant Vempati of Wysa brainstormed over a panel discussion the role for technology to assist in the management of NCDs. These entrepreneurs are the torch-bearers for partnerships and collaboration - whether it is partner labs for novel biomarker detection, or pharma to dole out drug-device combination therapeutics for diabetes mellitus, they spoke of the importance of collaboration between different stakeholders of the healthcare ecosystem. Dr RR Kasliwal, practising Cardiologist and Chairman of Medanta Medcity, a large provider in India, gave a thumbs up to the groundbreaking work that entrepreneurs are doing to make healthcare more empowered with the use of digital. He is a believer and alluded to his experience with using cardiac imaging for early diagnosis and timely intervention as an example for why technology is of utmost importance to Indian providers and patients today.

It isn’t all rainbows and butterflies, though. The panel clearly conveyed that a chasm exists between those designing/ building these technologies and clinicians who prescribe or use them - if Europe and the USA complain of lack of physician adoption and buy in, the burden of the problem in India is much larger.



Digital Health Moolah in India

Sandeep Singhal from Nexus Ventures, and our very own Martin Kelly and Jim Joyce (CEO,Health Beacon/ Director HealthXL), sat together in a casual discussion on the investment landscape for digital health in India. Sandeep, through his work in Silicon Valley (USA) and Silicon Valley + beyond (India) drew comparisons, and spoke of the need for more doctor-entrepreneurs and doctor-investors in India. The blossoming intersection of business, tech and healthcare that exists in the USA, making it ripe for investment is only nascent in India. But having said that, there is growing appetite and rupees going into digital health in India. Entrepreneurs, it is more important to first focus on engagement, and monetisation will follow.



Big Data for Improved Patient Outcomes: Case Studies from India

The size of the Indian population creates many problems, but it also generates tons of data. If harnessed properly, such large amounts of data have the potential to guide many healthcare decisions.

In the final session of the day, Arvind Sivaramakrishnan, CHCIO of Apollo Hospitals (an integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics), suggested that healthcare is definitely late to the digital party in India. But Apollo hospitals are ahead of the pack - using big data analytics, they have created India specific CVD risk scores based on hundreds of thousands of patient data points, and several risk factors. This is an important milestone as existing CVD risk scores (such as Framingham) are not wholly applicable to the Indian population.

Nakull Gupta, COO of Everwell, showed us how they are using the abundant data they have collected via their tracking solution as part of the TB (tuberculosis) DOTS program in India. They have identified patterns of medication adherence for better intervention (imagine reducing the number of community visits by a social worker to only those that really need it based on their medication taking patterns).

On the panel was data big-wig Amit Mookim, Managing Director of IQVIA India, Arun Kumar, Head of South Asia for Bayer Environmental Sciences, Kishor Joshi from Teleradsol who are using ML to run imaging analytics. There was consensus across the team on the onus on all parties to share and pool data to have more enriched insights, the importance of collaboration between public and private players because one has the data and the other has the tools to interpret it effectively, data driven insights have reduced healthcare costs and increased revenues. It emerged that there is already some semblance of value based care emerging in India and if we can harness the power of data that we have as a nation (and not just view it as too much unmeaningful, confusing data), the outcomes can be a shining example for the world.



Things We Learned

All in all, a fantastic and stimulating day of discussion and exchange among key individuals in Indian healthcare. HealthXL enjoyed its first Indian rendezvous. And for me personally, it was a wonderful coming together of my Indian and Irish personal and professional lives. Check out the event report below for an overview of the sessions, agenda and some pictures.

Namaste.

Event Report

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Best routes to market for DTx in the EU

18th October @ 10:45AM EDT

Join us as we discuss the best routes to market for DTx in the EU. These 75 minute sessions are guaranteed to be filled with interesting debate and valuable insights, apply now to secure your place.

Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Companion DTx: clinical & economic evidence

20th October @ 10:45AM EDT

Join our Digital Health Meeting focused on Companion DTx: clinical and economic evidence. This informal conversation brings a variety of stakeholders together to discuss and share their thoughts and experiences around this topic.

Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

DTx last mile delivery - HCPs and patients adoption

2nd November @ 11:45AM EDT

Join us in this informal conversation where we will discuss the main challenges around HCP and Patient adoption of DTx. Apply now to connect with peers and learn from fellow thought leaders in this space.

Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Tech Giants, Start-ups or Incumbents, who will disrupt healthcare?

4th November @ 11:30AM EDT

Join our Digital Health Meeting as discuss How do we define disruption in the healthcare industry? What is the ‘extinction event’ healthcare needs and why has it not happened yet? And what are the learnings from Tech Giants’ moves in healthcareApply now to join the conversation and share your thoughts on the topic.

Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Conor Hayes
Conor Hayes
Healthcare Lead, Techvie Software
Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Conor Hayes
Conor Hayes
Healthcare Lead, Techvie Software

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Best routes to market for DTx in the EU

18th October @ 10:45AM EDT

Join us as we discuss the best routes to market for DTx in the EU. These 75 minute sessions are guaranteed to be filled with interesting debate and valuable insights, apply now to secure your place.

Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Companion DTx: clinical & economic evidence

20th October @ 10:45AM EDT

Join our Digital Health Meeting focused on Companion DTx: clinical and economic evidence. This informal conversation brings a variety of stakeholders together to discuss and share their thoughts and experiences around this topic.

Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
AI in Healthcare
AI in Healthcare
AI in Healthcare
AI in Healthcare

Masterclass: AI-based diagnostics - learnings from a real-world use case

21st October @ 9:00AM GMT

In this masterclass, Zachary Tan (Advisor at CancerAid; Venture Creation Partner at Aegis Ventures; more info here) & Lisa Zhu (Research Fellow of the Center for Eye Research Australia) will walk us through the key learnings from their latest article in Scientific Reports (Nature) on real-world AI-based screening for diabetic retinopathy in Australia. This early-stage study is one of the first globally to describe the real-world implementation of AI in healthcare.

Featuring
Zachary Tan
Zachary Tan
Venture Creation Partner, Aegis Ventures
Lisa Zhu
Lisa Zhu
Research Fellow, CERA
Featuring
Zachary Tan
Zachary Tan
Venture Creation Partner, Aegis Ventures
Lisa Zhu
Lisa Zhu
Research Fellow, CERA
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology

Digital Health in Mental Health: Commercialization Models

21st October @ 10:45AM EDT

Join us in this informal conversation where we will discuss the best commercialisation models for digital companies in the mental health space. Our 75 minute sessions are guaranteed to be filled with interesting debate and great conversation.

Featuring
Robert Garber
Robert Garber
Partner, 7Wire Ventures
Sarah Fisher
Sarah Fisher
Senior Director, Global Markets, External Innovation, Johnson & Johnson Medical Devices
Featuring
Robert Garber
Robert Garber
Partner, 7Wire Ventures
Sarah Fisher
Sarah Fisher
Senior Director, Global Markets, External Innovation, Johnson & Johnson Medical Devices

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.